BEVACIZUMAB (BV) IN COMBINATION WITH FOLFOXIRI (IRINOTECAN, OXALIPLATIN AND INFUSIONAL 5FU/LV) AS FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER (mCRC): A PHASE II TRIAL BY THE GONO GROUP
Autor: | Masi, G., Vasile, E., Loupakis, F., Salvatore, L., Mezi, Silvia, Andreuccetti, Rondini M., Falcone, A. |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2009 |
Databáze: | OpenAIRE |
Externí odkaz: |